These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 18352844)
1. Immunotherapy for gastrointestinal cancer: current status and strategies for improving efficacy. Elkord E; Hawkins RE; Stern PL Expert Opin Biol Ther; 2008 Apr; 8(4):385-95. PubMed ID: 18352844 [TBL] [Abstract][Full Text] [Related]
2. Immune Therapy in GI Malignancies: A Review. Wang J; Reiss KA; Khatri R; Jaffee E; Laheru D J Clin Oncol; 2015 Jun; 33(16):1745-53. PubMed ID: 25918295 [TBL] [Abstract][Full Text] [Related]
3. Immunotherapy for gastrointestinal malignancies. Toomey PG; Vohra NA; Ghansah T; Sarnaik AA; Pilon-Thomas SA Cancer Control; 2013 Jan; 20(1):32-42. PubMed ID: 23302905 [TBL] [Abstract][Full Text] [Related]
4. Gastrointestinal cancer stem cells as targets for innovative immunotherapy. Chivu-Economescu M; Necula LG; Matei L; Dragu DL; Neagu AI; Alexiu I; Bleotu C; Diaconu CC World J Gastroenterol; 2020 Apr; 26(14):1580-1593. PubMed ID: 32327907 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic vaccination in patients with gastrointestinal malignancies. A review of immunological and clinical results. Mosolits S; Ullenhag G; Mellstedt H Ann Oncol; 2005 Jun; 16(6):847-62. PubMed ID: 15829493 [TBL] [Abstract][Full Text] [Related]
12. Immunotherapy-based combination strategies for treatment of gastrointestinal cancers: current status and future prospects. Zhou C; Zhang J Front Med; 2019 Feb; 13(1):12-23. PubMed ID: 30796606 [TBL] [Abstract][Full Text] [Related]
13. Pancreatic cancer: role of the immune system in cancer progression and vaccine-based immunotherapy. Amedei A; Niccolai E; Prisco D Hum Vaccin Immunother; 2014; 10(11):3354-68. PubMed ID: 25483688 [TBL] [Abstract][Full Text] [Related]
14. Targeted Immunotherapies in Gastrointestinal Cancer: From Molecular Mechanisms to Implications. Wang DK; Zuo Q; He QY; Li B Front Immunol; 2021; 12():705999. PubMed ID: 34447376 [TBL] [Abstract][Full Text] [Related]
15. The role of antigen-specific and non-specific immunotherapy in the treatment of cancer. Monjazeb AM; Hsiao HH; Sckisel GD; Murphy WJ J Immunotoxicol; 2012; 9(3):248-58. PubMed ID: 22734880 [TBL] [Abstract][Full Text] [Related]
16. Intratumoral immunotherapy: using the tumor as the remedy. Marabelle A; Tselikas L; de Baere T; Houot R Ann Oncol; 2017 Dec; 28(suppl_12):xii33-xii43. PubMed ID: 29253115 [TBL] [Abstract][Full Text] [Related]
17. Cancer immunotherapy: moving forward with peptide T cell vaccines. Kumai T; Fan A; Harabuchi Y; Celis E Curr Opin Immunol; 2017 Aug; 47():57-63. PubMed ID: 28734176 [TBL] [Abstract][Full Text] [Related]
18. The present status and future prospects of peptide-based cancer vaccines. Hirayama M; Nishimura Y Int Immunol; 2016 Jul; 28(7):319-28. PubMed ID: 27235694 [TBL] [Abstract][Full Text] [Related]
19. Immunotherapy as a Therapeutic Strategy for Gastrointestinal Cancer-Current Treatment Options and Future Perspectives. Koustas E; Trifylli EM; Sarantis P; Papadopoulos N; Karapedi E; Aloizos G; Damaskos C; Garmpis N; Garmpi A; Papavassiliou KA; Karamouzis MV; Papavassiliou AG Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743107 [TBL] [Abstract][Full Text] [Related]
20. Immunotherapy in gastrointestinal cancer: The current scenario and future perspectives. Abdul-Latif M; Townsend K; Dearman C; Shiu KK; Khan K Cancer Treat Rev; 2020 Aug; 88():102030. PubMed ID: 32505807 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]